Krensavage Asset Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $235 Million distributed in 17 stocks.

Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $40.9M, Enanta Pharmaceuticals Inc with a value of $25.3M, Jazz Pharmaceuticals PLC with a value of $22.1M, Biomarin Pharmaceutical Inc with a value of $22M, and Exelixis, Inc. with a value of $21.4M.

Examining the 13F form we can see an increase of $45.8M in the current position value, from $189M to 235M.

Krensavage Asset Management, LLC is based out at New York, NY

Below you can find more details about Krensavage Asset Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $235 Million
Healthcare: $200 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 17
  • Current Value $235 Million
  • Prior Value $189 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 3 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Krensavage Asset Management, LLC Portfolio

Follow Krensavage Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.